Upkar Remedies Private Limited
Medical company providing healthcare services and manufacturing and distributing medicines and medical supplies.
1994 | Chennai, Tamil Nadu (India) | Active
Upkar Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 0.22 M
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.10 Cr
- Satisfied Charges ₹ 2.10 Cr
- Revenue Growth -63.18%
- Profit Growth 80.29%
- Ebitda -312.79%
- Net Worth 46.72%
- Total Assets -13.43%
About Upkar Remedies
Upkar Remedies Private Limited (URPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 January 1994 and has a history of 31 years and one month. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹5.10 Cr. The company has closed loans amounting to ₹2.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Motilal Shah and Sobhagmal Kalpesh serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1994PTC026647
- Company No.
026647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Who are the key members and board of directors at Upkar Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Motilal Shah  | Director | 02-Dec-1996 | Current |
| Sobhagmal Kalpesh | Director | 02-Dec-1998 | Current |
Financial Performance of Upkar Remedies.
Upkar Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.18% decrease. The company also saw a substantial improvement in profitability, with a 80.29% increase in profit. The company's net worth Soared by an impressive increase of 46.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Upkar Remedies?
In 2023, Upkar Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹5.10 Cr
Satisfied Charges
₹2.10 Cr
Charges Breakdown by Lending Institutions
- Others : 4.90 Cr
- Corporation Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2018 | Others | ₹4.90 Cr | Open |
| 28 Feb 2002 | Corporation Bank | ₹2.00 M | Open |
| 19 Nov 2012 | Icici Bank Limited | ₹2.10 Cr | Satisfied |
How Many Employees Work at Upkar Remedies?
Unlock and access historical data on people associated with Upkar Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Upkar Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upkar Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.